Cargando...
RESPONSE TO ANDREW DUNNING’S COMMENT ON “EVALUATING A SURROGATE ENDPOINT AT THREE LEVELS, WITH APPLICATION TO VACCINE DEVELOPMENT”
In replying to Andrew Dunning’s helpful letter, we endeavor to clarify the value of incorporating baseline participant predictors of the potential surrogate endpoint and of the clinical endpoint into the evaluation of a surrogate endpoint. Such baseline predictors are useful for the evaluation of su...
Gardado en:
| Publicado en: | Stat Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2009
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4510047/ https://ncbi.nlm.nih.gov/pubmed/19140113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.3503 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|